Provision of cardiovascular protection by ACE inhibitors: a review of recent trials

Author： Bertrand Michel E.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.20, Iss.10, 2004-10, pp. : 1559-1569

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: A Review of Recent Clinical Trials

By  

Reviews on Recent Clinical Trials, Vol. 2, Iss. 2, 2007-05 ,pp. : 117-120

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Clinical Trials of Pharmacologic Cardiovascular Interventions in Patients with Chronic Kidney Disease

By  

Reviews on Recent Clinical Trials, Vol. 3, Iss. 2, 2008-05 ,pp. : 79-88

Bentham Science Publishers

Access to resources Recommend Favorite

Review: Recent Clinical Trials in Epigenetic Therapy

By  

Reviews on Recent Clinical Trials, Vol. 1, Iss. 2, 2006-05 ,pp. : 169-182

Bentham Science Publishers

Access to resources Recommend Favorite

ACE inhibitors, angiotensin receptor blockers and direct renin inhibitors in combination: a review of their role after the ONTARGET trial

By Düüsing Rainer   Sellers Felicity  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2287-2301

Informa Healthcare

Access to resources Recommend Favorite

Clinical Trials of Poly(ADP-Ribose) Polymerase Inhibitors for Cancer Therapy: A Review

By  

Reviews on Recent Clinical Trials, Vol. 10, Iss. 4, 2015-12 ,pp. : 326-339

Bentham Science Publishers

Access to resources Recommend Favorite